Chapter 11 - Alzheimer's Disease Flashcards

1
Q

What is dementia?

A
  • umbrella term referring to changes in cognitive function great enough to interfere w/ daily function
  • called neurocognitive disorder in the DSM5
  • degenerative
  • most common is AZ
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is MCI?

A
  • clinical diagnosis describing the transitional state btwn normal aging and mild dementia
  • pts @ a greater risk for developing AZ
  • mild mem impairment w/ preservation of other cog functions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Amnestic MCI

A
  • cognitive impairment limited to episodic memory
  • 80% pts progress to AZ
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Amnestic Multiple Domain MCI

A
  • mild impairment on multiple domains such as mild behavioral changes, executive dysfunction, and visuospatial deficits
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Non-amnestic Single Domain MCI

A
  • mild isolated cog impairment of behavior, executive function, lang., visuospatial processing
  • NOT episodic memory
  • high risk for other dementias
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Non-amnestic Multiple Domain MCI

A
  • mild cog impairment on multiple domains such as mild behavioral changes, executive dysfunction, visuospatial deficits
  • NOT episodic memory
  • high risk for other dementias
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Clinical description of MCI

A
  • pt has memory complaint
  • memory dysfunction for age and education
  • largely intact activities of daily living
  • not demented
  • use of the Clinical Dementia Rating Scale and the Global Deterioration Scale
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the risk factors for AZ?

A
  • increasing age
  • presence of APOE e4 increases risk
  • CV disease
  • TBI
  • depression
  • lower educational achievement
  • Down syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Clinical evolution of AZ can be divided into 3 categories, what are they?

A
  1. progressive memory impairment
  2. progressive cortical dysfunction
    - neuropsychiatric disturbances
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

AZ has an ________ onset and a _______ progression of an amnesic memory disturbance with difficulties of _________ and _____.

A
  • insidious
  • gradual
  • learning
  • recall
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Early stage of AZ

A
  • aka mild
  • STM loss, difficulty w/ recall
  • changes in language
  • changes in mood
  • decreased judgement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Clinical manifestations of AZ

A
  • cog impairment, mainly episodic
  • behavioral disturbances (aggression, delusions, wandering)
  • affective disturbances (changes in mood and personality)
  • motor impairments (seen towards late stages, resembles Parkinson’s)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Mild stage of AZ

A
  • aka moderate
  • personality changes,
  • LTM loss
  • behavioral problems (agitation, anxiety, aggression, wandering, insomnia)
  • needing assistance in daily activities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

End stage of AZ

A
  • aka severe
  • behavioral changes
  • loss of ability to perform daily activities
  • incontinence
  • loss of motor skills
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Diagnosis of AZ

A
  • MMSE
  • general neurologic exam
  • health hx
  • CT or MRI to see atrophy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Amyloid plaques

A
  • neuritic plaques caused by the abnormal processing of amyloid-beta proteins
  • lead to excitotoxicity and apoptosis
17
Q

Neurofibrillary tangles

A
  • Tau, a microtubule stabilizing protein, clump together in pts with AZ
  • microtubules collapse
18
Q

What neurotransmitter is affected in AZ?

A

acetylcholine
- cholinergic neurons are lost in the basal forebrain
glutamate
- reduction of NMDA receptors in the hippocampus

19
Q

Genetic factors of AZ

A
  • abnormal amyloid precursor protein (21q)
  • PSEN1 and PSEN2
  • apolipoprotein E e4 allele (APOEe4) increases risk, APOEe2 decreases risk
20
Q

What are the nonpharmacological tx for AZ?

A
  • CBT
  • support
21
Q

What are the pharmacological tx for AZ?

A
  • cholinesterase inhibitors and NMDA are the known treatments
  • antidepressants, anxiolytics, antipsychotics, mood stabilizers, sleep medications are used for adjunctive treatment
22
Q

Cholinesterase inhibitors

A
  • AChase is the enzyme responsible for breaking down ACh
  • cholinesterase inhibitors will reduce the breakdown of ACh, thus preserving cognition
  • cannot regain lost function and memory or protect neurons from degeneration
  • useful for mild-moderate AZ
  • adverse affects: headache, high BP, dizziness, heart burn
23
Q

EX of cholinesterase inhibitors

A
  • most common in Aricept
  • transdermal Exelon patch (no swallowing, less side effects)
24
Q

NMDA receptor agonists

A
  • the lack of reuptake of glutamate by NMDA receptors has excitotoxic effects in pts with AZ
  • can preserve cog, social and motor impairment
  • cannot protect neurons from degeneration
  • used for moderate-severe AZ
25
Q

Preventative strategies for AZ

A
  • manage of CV risk factors like high cholesterol, high BP, obesity
  • maintaining mental activity